Coronavirus disease (COVID-19) is an infectious disease caused by the coronavirus SARS-CoV-2. Here we have collected APR news related to the COVID-19 pandemic, vaccination efforts and emerging treatments.
Tuesday, January 04, 2022
BiondVax Pharmaceuticals Ltd. has announced the signing of definitive agreements with the Max Planck Society (MPG), the parent organization of the Max Planck Institute of Biophysical Chemistry, and ...
read more
Tuesday, January 04, 2022
Merck and Ridgeback Biotherapeutics announced that the United Kingdom Government will purchase an additional 1.75 million patient courses of molnupiravir (MK-4482), an investigational oral antiviral ...
read more
Monday, December 20, 2021
Sirona Biochem Corp. announced the advancement of 20 antiviral compounds to In Vitro testing. The compounds will be shipped to the Utah State University's Institute of Antiviral Research for ...
read more
Monday, December 20, 2021
Providence Therapeutics and Everest Medicines announced that their COVID-19 vaccine, PTX-COVID19-B, has been recommended by an independent advisory group to be part of the Solidarity Trial Vaccines ("...
read more
Friday, December 17, 2021
Medicago, a biopharmaceutical company headquartered in Quebec City, announced the submission of positive Phase 3 data for regulatory review by Health Canada as part of the New Drug Submission for ...
read more
Friday, December 17, 2021
Merck and Ridgeback Biotherapeutics announced that the New England Journal of Medicine has published findings from the Phase 3 MOVe-OUT trial evaluating molnupiravir, an investigational oral antiviral...
read more
Thursday, December 16, 2021
Vaxart, Inc. plans to test the cross-reactivity of its oral tablet COVID-19 vaccine candidate against the Omicron SARS-CoV-2 variant in two different studies expected to begin next month.
In the ...
read more
Thursday, December 16, 2021
AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination for the prevention of COVID-19, retained neutralizing activity against the Omicron SARS-CoV-2 ...
read more
Wednesday, December 15, 2021
Kaiser Permanente research in Southern California published Nov. 25, 2021, in The Lancet Regional Health – Americas confirmed high Moderna COVID-19 vaccine effectiveness up to 5 months after the ...
read more
Wednesday, December 15, 2021
Merck announced that the European Commission (EC) has approved VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for active immunization for the prevention of invasive disease and pneumonia ...
read more
Monday, December 13, 2021
Novavax Files for Emergency Use of COVID-19 Vaccine in the United Arab Emirates
Novavax, Inc. has submitted a regulatory filing to the Ministry of Health and Prevention (MoHaP) for emergency use of ...
read more
Monday, December 13, 2021
Clinical Enterprise, Inc., a Eurofins Scientific Company, has launched a new partnership with Ginkgo Bioworks to support Operation Expanded Testing Program with the U.S. Department of Health and Human...
read more
Friday, December 10, 2021
Pfizer Inc. and BioNTech SE announced that the FDA has expanded the Emergency Use Authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 16 years of age ...
read more
Thursday, December 09, 2021
AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorization (EUA) in the US for the pre-exposure prophylaxis (...
read more
Wednesday, December 08, 2021
Pfizer Inc. and BioNTech SE announced results from an initial laboratory study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 ...
read more